Schonfeld Strategic Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.58M Sell
122,507
-338,741
-73% -$26.5M 0.07% 314
2025
Q1
$33.4M Buy
461,248
+339,862
+280% +$24.6M 0.2% 61
2024
Q4
$8.99M Buy
121,386
+70,201
+137% +$5.2M 0.05% 300
2024
Q3
$3.38M Buy
+51,185
New +$3.38M 0.02% 568
2023
Q4
Sell
-181,691
Closed -$12.6M 1848
2023
Q3
$12.6M Buy
181,691
+173,904
+2,233% +$12M 0.1% 260
2023
Q2
$735K Buy
+7,787
New +$735K 0.01% 1065
2022
Q4
Sell
-183,500
Closed -$15.2M 2613
2022
Q3
$15.2M Buy
+183,500
New +$15.2M 0.13% 227
2022
Q2
Sell
-118
Closed -$14K 2559
2022
Q1
$14K Buy
+118
New +$14K ﹤0.01% 2329
2021
Q4
Sell
-12,100
Closed -$1.37M 2083
2021
Q3
$1.37M Sell
12,100
-46,342
-79% -$5.25M 0.01% 774
2021
Q2
$6.05M Buy
+58,442
New +$6.05M 0.06% 390
2021
Q1
Sell
-17,900
Closed -$1.63M 1828
2020
Q4
$1.63M Sell
17,900
-36,830
-67% -$3.36M 0.02% 626
2020
Q3
$4.37M Sell
54,730
-30,206
-36% -$2.41M 0.08% 303
2020
Q2
$5.87M Buy
+84,936
New +$5.87M 0.15% 185
2020
Q1
Sell
-81,300
Closed -$6.32M 1241
2019
Q4
$6.32M Buy
+81,300
New +$6.32M 0.15% 162
2019
Q3
Sell
-211,416
Closed -$13M 1060
2019
Q2
$13M Buy
211,416
+199,281
+1,642% +$12.3M 0.46% 51
2019
Q1
$774K Sell
12,135
-10,365
-46% -$661K 0.03% 573
2018
Q4
$1.15M Buy
+22,500
New +$1.15M 0.04% 445
2018
Q3
Sell
-98,658
Closed -$4.79M 840
2018
Q2
$4.79M Sell
98,658
-163,851
-62% -$7.95M 0.26% 128
2018
Q1
$12.2M Sell
262,509
-10,479
-4% -$487K 0.92% 9
2017
Q4
$10.3M Buy
272,988
+62,955
+30% +$2.37M 0.84% 8
2017
Q3
$7.65M Buy
210,033
+204,180
+3,488% +$7.44M 0.7% 23
2017
Q2
$231K Sell
5,853
-55,065
-90% -$2.17M 0.02% 527
2017
Q1
$1.91M Sell
60,918
-76,902
-56% -$2.41M 0.19% 152
2016
Q4
$4.3M Buy
+137,820
New +$4.3M 0.56% 41
2016
Q3
Sell
-33,045
Closed -$1.1M 453
2016
Q2
$1.1M Buy
33,045
+24,828
+302% +$826K 0.25% 116
2016
Q1
$242K Buy
+8,217
New +$242K 0.1% 248